Navidea Biopharmaceuticals Earns Sell Rating from Analysts at StockNews.com
About 67% of Navidea Biopharmaceutica's investor base is looking to short. The analysis of overall sentiment of trading Navidea Biopharmaceuticals pink sheet suggests that many investors are alarmed at this time. The current market sentiment, together with Navidea Biopharmaceutica's historical and current headlines, can help investors time the market. In addition, many technical investors use Navidea Biopharmaceutica stock news signals to limit their universe of possible portfolio assets.
Navidea |
StockNews.com assumed coverage on shares of Navidea Biopharmaceuticals in a report released on Friday morning. The brokerage issued a sell rating on the stock. Navidea Biopharmaceuticals Stock Down 0.5 percent Shares of NYSE NAVB opened at 0.09 on Friday. Navidea Biopharmaceuticals has a twelve month low of 0.07 and a twelve
Read at thelincolnianonline.com
 |
Navidea Biopharmaceutica Fundamental Analysis
We analyze Navidea Biopharmaceutica's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Navidea Biopharmaceutica using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Navidea Biopharmaceutica based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Liabilities
Current Liabilities Comparative Analysis
Navidea Biopharmaceutica is currently under evaluation in current liabilities category among its peers. Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Navidea Biopharmaceutica Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Navidea Biopharmaceutica pink sheet to make a market-neutral strategy. Peer analysis of Navidea Biopharmaceutica could also be used in its relative valuation, which is a method of valuing Navidea Biopharmaceutica by comparing valuation metrics with similar companies.
Peers
Navidea Biopharmaceutica Related Equities
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Consideration for investing in Navidea Pink Sheet
If you are still planning to invest in Navidea Biopharmaceutica check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Navidea Biopharmaceutica's history and understand the potential risks before investing.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |